Ignite Creation Date:
2025-12-25 @ 1:26 AM
Ignite Modification Date:
2025-12-27 @ 11:01 PM
Study NCT ID:
NCT03959293
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-07-08
First Post:
2019-05-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Clinical Trial Evaluating FOLFIRI + Durvalumab vs FOLFIRI + Durvalumab and Tremelimumab in Second-line Treatment of Patients With Advanced Gastric or Gastro-oesophageal Junction Adenocarcinoma
Sponsor:
Federation Francophone de Cancerologie Digestive
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-07-17
Start Date Type:
ACTUAL
Primary Completion Date:
2022-03-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-11-27
Completion Date Type:
ESTIMATED
First Submit Date:
2019-05-09
First Submit QC Date:
None
Study First Post Date:
2019-05-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-05
Last Update Post Date:
2024-07-08
Last Update Post Date Type:
ACTUAL